Journal of Parasitic Diseases: Diagnosis and Therapy

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (629)348-3199

Announcement - Journal of Parasitic Diseases: Diagnosis and Therapy (2021) Volume 6, Issue 2

A warm welcome to authors for submission of their manuscript in our Journal.

Amelia Smith*

Editorial office, London, United Kingdom

Corresponding Author:
Amelia Smith
Editorial office, London, United Kingdom

Accepted date: March 21, 2021


First and foremost, we'd like to express our sincere appreciation to the editors of the Open Access Journal. Journal of Parasitic Disease: Diagnosis and Therapy has collaboration with more than 20 editorial board members and is successfully publishing quality articles in the field of parasitic disease. For quality control in the peer-review process, we use an Editorial Tracking System, which is an online manuscript submission, review, and tracking device. Review processing is handled by members of the Journal's editorial board or outside experts; each citable manuscript must be approved by at least two independent reviewers before being accepted by the publisher. Authors will send manuscripts and follow their progress through the tracking system.

As everyone is mindful that reviewers are very important in promoting the Editors' need to keep up exclusive standards of informative greatness in the work we distribute. We are extremely grateful for the invaluable work of our board individuals in contributing both to our rigorous companion audit framework and to the critical advancement of the Journal.

The Journal community includes global experts in similar logical distributions. To ensure delivery consistency, all submitted papers go through multiple stages. The compositions are subjected to the normal companion audit measure. There is preliminary scanning using an infinite quantity of paper. Fitting papers are then sent out, along with two free refs. The Editor-in- Chief, the person in charge of reaching a final decision, considers the arbitrators' comments. Giving prompt and constructive feedback to our respected authors remains a priority so that their art can be made available to the global community on time.

The COVID-19 epidemic has triggered widespread disruption, posing problems for all. Several researchers/technicians are also grappling with problems such as laboratory closures and the arrangement of online teaching while still dealing with the impact of this pandemic condition on their day-to-day lives. Many of the reporters, reviewers, and publishers of numerous publications are still doctors fighting the pandemic. As a result, delays during this pandemic time are unavoidable, and we would like to express our gratitude. It is important that our Editors and Editorial Advisory Board discuss the topics we distribute as well as represent the countries from which our entries come. Moreover, parasitic diseases resulting from endoparasites, tapeworms, flukes, roundworms, helminthes organisms, fleas, mites, lice, intestinal worms, coccidian, giardia etc.

The aim of Journal of Parasitic Disease: Diagnosis and Therapy is to provide readers with a wide range of clinical parasitic disease topics, such as surgical, endoscopic, interventional, and medicinal developments in cancer, inflammatory diseases, and functional gastrointestinal disorders.

Researchers/Scientists/Authors are encouraged to share their CV and research interests with us in order to become an Editorial Board Member, where they can cooperate together with the Editors and Reviewers and have the same high quality and fast review process.

If you are interested in joining our Reviewer Board, please give us an updated CV, research interests, biography, and a recent photograph (JPG) to

The editors are looking forward to partnering with our new hires over the next two years. I cordially invite all of our board members and extend a warm welcome to those who have elected to join our recognized list of researchers.

Get the App